Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-14 Purchase |
2022-06-15 4:05 pm |
Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. President/CSO |
30,000 | $0.62 | $18,600 | 34,500 (Direct) |
View |
| 2021-04-26 Purchase |
2021-04-26 6:16 pm |
Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. EVP, Chief Strategy Officer |
4,500 | $2.03 | $9,135 | 4,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-07-11 Option Award |
2022-08-04 4:16 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. President/CSO |
130,000 | $0 | 130,000 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 06:15 am |
N/A 2031-12-08 |
Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. President/ChiefStrategyOfficer |
300,000 | $0 | 304,500 (Direct) |
View |
| 2020-12-07 Option Award |
2020-12-29 4:44 pm |
N/A 2030-12-07 |
Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. Executive VP, CSO |
150,000 | $0 | 150,000 (Direct) |
View |
| 2020-08-27 Option Award |
2020-08-28 2:01 pm |
N/A 2030-08-27 |
Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. Director |
50,000 | $0 | 50,000 (Direct) |
View |